Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pronase for improving gastroscopic screening of early upper gastrointestinal cancers
ChiCTR2200064855Phase 4Recruiting
- Sponsor
- Wuwei Cancer Hospital of Gansu Province
- Start
- Oct 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of pronase in gastric cancer (GC) and upper gastrointestinal cancer (2 arms), sponsored by Wuwei Cancer Hospital of Gansu Province. Primary endpoints: Endoscopic visibility and Early cancer detection rate. Started Oct 2022; status: recruiting.
02
Drugs
pronase
03
Conditions
gastric cancer (GC)upper gastrointestinal cancer
Beyond the preview
Go deeper on ChiCTR2200064855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200064855.